Research

Mixed

In oncology patients, muscle-specific strength (MSS) estimated via anthropometry (body weight or calf circumference) or bioimpedance (BIA) provides a reliable alternative to DXA-derived MSS, enabling functional assessment in resource-limited settings.

For cancer patients or clinicians without access to DXA scanners, you can accurately estimate muscle quality by dividing handgrip strength by body weight or calf circumference. This method correlates very strongly with the gold standard DXA test, allowing for effective monitoring of sarcopenia and treatment response in routine clinical settings.

GoodSupportsHIGH confidence
MSS calculated with BIA, body weight, and calf circumference showed very strong correlations with MSS-DXA (r > 0.90)... BIA and anthropometric methods, particularly those using body weight and calf circumference, are reliable and accessible alternatives to DXA for estimating MSS in oncology patients.
Blanca Alabadí et al. · Life · 2025

Why this rating

Cross-sectional study with a large sample size (n=205) and rigorous statistical correlation analysis against the gold standard.

Source

Assessment of Muscle-Specific Strength in Oncology Patients: Anthropometry as a Reliable Alternative to DXA

Blanca Alabadí et al. · Life · 2025

DOI 10.3390/life15081300

cross_sectional · n=205Cited 1×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →